Talis Biomedical CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
Director Leonard Braden Michael reports acquisition of Talis Biomedical Corp shares through BML Investment Partners, L.P.
Director Leonard Braden Michael reports acquiring 500 shares of Talis Biomedical Corp common stock at $4 per share on September 3, 2024.
Director Leonard Braden Michael reports purchasing 151 shares of Talis Biomedical Corp at $4.25 on August 30, 2024, increasing his indirect holdings.
Director Leonard Braden Michael reports acquisition of Talis Biomedical Corp shares through BML Investment Partners, L.P.